Co‐expression of Hif1α and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients

Authors:

Abstract
J Oral Pathol Med (2010) 39: 313–317Background:  This study investigates the prognostic impact of the expression of hypoxia‐inducible factor 1α (Hif1α) and carbonic anhydrase IX (CAIX) detected by immunohistochemistry in oral squamous cell carcinoma (OSCC).Methods:  Statistical analysis of immunohistochemical results with clinical parameters including survival outcomes was performed for 80 OSCC patients.Results:  Patients with a low expression of both proteins survived on average 54.8 months, whereas those with an increased expression of Hif1α in their tumors combined with a low expression of CAIX survived on average only 37.6 months (P = 0.026). In multivariate Cox’s regression hazard analysis, again patients with a low expression of Hif1α/CAIX had the best prognosis, whereas patients with increased Hif1α and low CAIX expression carried a 4.97‐fold increased risk of tumor‐related death (P = 0.042).Conclusion:  A co‐detection of low Hif1α/CAIX expression is significantly correlated with a better prognosis for OSCC patients, which may have implications for therapy options for these patients.

This publication has 25 references indexed in Scilit: